期刊文献+

人乳头瘤病毒E7与人干扰素α-2b融合基因在中国仓鼠卵巢细胞中的表达 被引量:1

The construction of eukaryotic expression plasmid of HPV11-E7/human IFNα-2b fusion gene and its expression in CHO
下载PDF
导出
摘要 目的:构建人乳头瘤病毒(HPV)11-E7及人干扰素(IFN)α-2b的真核表达载体,并在中国仓鼠卵巢(CHO)细胞中表达。方法:同时用KpnⅠ、EcoRⅠ酶切pET-32a-IFNα-2b-linker-HPV11-E7及pcDNA3.1,将酶切产物纯化回收,两者的回收产物进行连接反应。连接产物转化大肠杆菌感受态细胞DH5α,随机挑选阳性克隆并提取质粒酶切鉴定;用脂质体法转染CHO细胞,用免疫荧光法检测融合基因的表达。结果:DNA测序结果显示,成功地将IFN-α-2b-linker-HPV11-E7装入pcDNA3.1的KpnⅠ、EcoRⅠ酶切位点之间,且其序列与设计完全一致;激光扫描共聚焦显微镜观察可见目的蛋白的表达。结论:成功地构建了HPV11-E7及IFNα-2b的真核表达载体,并在CHO细胞中表达,为提高DNA疫苗免疫效果的研究奠定了基础。 Objective: To construct the expression plasmid of HPV11-ET/ human IFNα-2b fusion gene and express the fu- sion gene in Chinese Hamster Ovary (CHO) cell. Methods: pET-32α-IFNα-2b-linker-HPV11-E7 and pcDNA3.1 were digested by Kpn Ⅰ and EcoR Ⅰ, digested products were linked by T4 DNA ligase. DH5α was transformed with the linked product, positive clones were identified after Kpn Ⅰ and EcoR Ⅰ digestion. The recombinant plasmid carrying HPV11-E7/ human IFNα-2b fusion gene was introduced into CHO cells by lipofectin. The CHO cell containing pcDNA3.1 (+)-IFNα-2b-linker- HPV11-E7 was examined by immunofluorescence staining. Results: The DNA sequencing showed that HPV11-ET/ human IFNα-2b fusion gene was successfully inserted into the pcDNA3.1(+) plasmid between Kpn Ⅰ and EcoR Ⅰ. Conclusion: The successful construction of eukaryotic expression plasmid of HPVll-ET/ human IFNα-2b fusion gene and its expression in CHO cells may establish the base for increasing immunological result of DNA vaccine.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2006年第7期430-432,共3页 Journal of Clinical Dermatology
基金 江苏省重点学科基金资助项目(135-03) 国家自然科学基金资助项目(30100156)
关键词 人乳头瘤病毒 E7基因 干扰素Α-2B 融合基因 human papillomavirus E7 gene IFNα-2b fusion gene
  • 相关文献

参考文献10

  • 1Cheah PL,Looi LM.Biology and pathological associations of the human papillomaviruses:a review[J].Malays J Pathol,1998,20(1):1-10
  • 2党育平,王刚,范雪莉,沈柱,樊建勇,刘玉峰.人乳头瘤病毒6型E7与结核杆菌热休克蛋白70融合基因的构建及原核表达[J].临床皮肤科杂志,2005,34(4):208-210. 被引量:1
  • 3Gurunathan S,Klinman DM,Seder RA,DNA vaccines:immunology,application,and optimization[J].Annu Rev Immunol,2000,18:927-974
  • 4Jonaseh E.Haluska FG.Interferon in oncological practice:review of interferon biology,elinical applications.and toxicities[J].Oncologist,2001,6(1):34-55
  • 5Tracey L,Spiteri I.Ortiz P,et al.Transcriptional response of T cells to IFN-alpha:changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma[J].J Interferon Cytokine Res,2004,24(3):185-195
  • 6van den Broek MF,Muller U,Huang S,et al.Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors[J].J Virol,1995,69(8):4792-4796
  • 7Luft T.Luetjens P.Hochrein H,et al.IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells[J].Int Immunol,2002,14(4):367-380
  • 8Santini SM,Lapenta C.Logozzi M,et al.Type 1 interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice[J].J Exp Med,2000,191(10):1777-1788
  • 9Radvanyi LG,Banerjee A,Weir M,et al.Low levels of interfer-on-alpha induce CD86(B7.2)expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells[J].Scand J Immunol,1999,50(5):499-509
  • 10Prummer O,Seyfarth C,Scherbaum WA,et al.Interferon-alpha antibodies in autoimmune diseases[J].J Interferon Res,1989,9(Suppl)1:S67-S74

二级参考文献5

  • 1Brentjens MH, Yeung-Yue KA, Lee PC, et al. Human papillomavirus: a review[J]. Dermatol Clin, 2002, 20(2): 315-331.
  • 2Lussow AR, Barrios C, van Embden J, et al. Mycobacterial heatshock proteins as carrier molecules[J]. Eur J Immunol, 1991, 21(10): 2297-2302.
  • 3McMurray HR, Nguyen D, Westbrook TF, et al. Biology of human papillomaviruses[J]. Int J Exp Pathol, 2001, 82(1):15-33.
  • 4Flores ER, Allen-Hoffmann BL, Lee D, et al. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle[J]. J Virol, 2000, 74(14): 6622-6631.
  • 5Suzue K, Young RA. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24[J].J Immunol, 1996, 156(2): 873-879.

同被引文献7

  • 1相文忠,王飞,李光富,王新军,王群,刘丰,张兆松,毕志刚.HPV11-E7与人干扰素α-2b融合表达质粒的构建及表达[J].中华皮肤科杂志,2005,38(10):640-642. 被引量:1
  • 2Chow YH, Huang WL, Chi WK, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol, 1997, 71 (1): 169-178.
  • 3Barouch DH, Letvin NL, Seder RA. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev, 2004, 202(3 ): 266-274.
  • 4Hsu KF, Hung CF, Cheng WF, et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther, 2001, 8(5): 376-383.
  • 5Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res, 2000, 60(4): 1035-1042.
  • 6Tracey L, Spiteri I, Ortiz P, et al. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. J Interferon Cytokine Res, 2004, 24(3): 185-195.
  • 7Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist, 2001, 6 (1): 34-55.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部